(sye'' la stat' in soe' dee um).
2-Heptenoic acid, 7-[(2-amino-2-carboxyethyl)thio]-2-[[(2,2-dimethylcyclopropyl)carbonyl]amino]-, monosodium salt, [R-[R*,S*-(Z)]]-.
Sodium (Z)-7-[[(R)-2-amino-2-carboxyethyl]thio]-2-[(S)-2,2-dimethylcyclopropanecarboxamido]-2-heptenoate [81129-83-1].
» Cilastatin Sodium contains not less than 98.0 percent and not more than 101.5 percent of C16H25N2NaO5S, calculated on the anhydrous and solvent-free basis.
Packaging and storage Preserve in Containers for Sterile Solids as described under Injections 1, and store in a cold place.
Labeling Where it is intended for use in preparing injectable dosage forms, the label states that it is sterile.
USP Reference standards 11
USP Endotoxin RS
A: The retention time of the major peak for cilastatin in the chromatogram of the Test solution, as obtained in the test for Chromatographic purity, corresponds to that in the chromatogram of a similar preparation of USP Cilastatin Ammonium Salt RS.
B: Ignite a small portion of it on a platinum wire in a nonluminous flame: an intense yellow color is imparted to the flame.
Specific rotation 781S: between +41.5 and +44.5, on the anhydrous and solvent-free basis.
Test solution: 10 mg per mL, in a mixture of methanol and hydrochloric acid (120:1).
Bacterial endotoxins 85 Where the label states that Cilastatin Sodium is sterile, it contains not more than 0.17 USP Endotoxin Unit per mg of cilastatin.
Sterility 71 Where the label states that Cilastatin Sodium is sterile, it meets the requirements when tested as directed for Membrane Filtration under Test for Sterility of the Product to be Examined, 6 g of specimen dissolved in 200 mL of Fluid A being used.
pH 791: between 6.5 and 7.5, in a solution (1 in 100).
Water, Method I 921: not more than 2.0%.
Heavy metals, Method II 231: 0.002%.
Limit of solvents
Internal standard solution Transfer 0.5 mL of n-propyl alcohol to a 1000-mL volumetric flask, dilute with water to volume, and mix.
Standard solution Transfer 2.0 mL of acetone, 0.50 mL of methanol, and 0.50 mL of mesityl oxide to a 1000-mL volumetric flask, dilute with water to volume, and mix. Transfer 2.0 mL of this solution and 2.0 mL of Internal standard solution to a 10-mL volumetric flask, dilute with water to volume, and mix. This solution contains 316 µg of acetone, 79 µg of methanol, and 86 µg of mesityl oxide per mL.
Test solution Transfer about 200 mg of Cilastatin Sodium, accurately weighed, to a 10-mL volumetric flask, add 2.0 mL of Internal standard solution and about 5 mL of water, and dissolve by shaking. Dilute with water to volume, and mix.
Chromatographic system (see Chromatography 621)The gas chromatograph is equipped with a flame-ionization detector and a 0.53-mm × 30-m capillary column, the internal wall of which is coated with a 1.0-µm film of liquid phase G16. The column temperature is maintained at 50 for 2.5 minutes, then increased at a rate of 8 per minute to 70, and maintained at 70 for 0.5 minute; the injection port temperature is maintained at 160; the detector temperature is maintained at 250; and helium is used as the carrier gas at a flow rate of about 9 mL per minute. Chromatograph the Standard solution, and record the peak responses as directed for Procedure: the relative retention times are about 0.26 for acetone, 0.35 for methanol, 0.67 for n-propyl alcohol, and 1.0 for mesityl oxide; and the relative standard deviation for replicate injections, determined from peak area ratios of each analyte to n-propyl alcohol, is not more than 5.0%.
Procedure Separately inject equal volumes (about 1 µL) of the Standard solution and the Test solution into the chromatograph, using the solvent (water) flush technique; record the chromatograms; and measure the areas for the acetone, methanol, n-propyl alcohol, and mesityl oxide peaks. Calculate the percentages of acetone, methanol, and mesityl oxide in the portion of Cilastatin Sodium taken by the formula:
(C/W)(RU / RS)in which C is the concentration, in µg per mL, of the appropriate analyte in the Standard solution; W is the quantity, in mg, of Cilastatin Sodium taken to prepare the Test solution; and RU and RS are the peak area ratios of the corresponding analyte to n-propyl alcohol obtained from the Test solution and the Standard solution, respectively. Not more than 1.0% of acetone is found; not more than 0.5% of methanol is found; and not more than 0.4% of mesityl oxide is found.
Solvent Use water.
Solution A Prepare a mixture of dilute phosphoric acid (1 in 1000) and acetonitrile (700:300), pass through a filter having a 0.5-µm or finer porosity, and degas.
Solution B Use dilute phosphoric acid (1 in 1000). Pass through a filter having a 0.5-µm or finer porosity, and degas.
Mobile phase Use variable mixtures of Solution A and Solution B as directed for Chromatographic system. Make adjustments if necessary (see System Suitability under Chromatography 621).
Test solution Prepare a solution of Cilastatin Sodium in Solvent having a concentration of about 1.6 mg per mL.
Chromatographic system (see Chromatography 621)The liquid chromatograph is equipped with a 210-nm detector and a 4.5-mm × 25-cm column containing packing L1. The column is maintained at a constant temperature of about 50. The flow rate is about 2 mL per minute. The chromatograph is programmed as follows.
Procedure Separately inject equal volumes (about 20 µL) of the Test solution and the Solvent into the chromatograph, record the chromatograms, and measure the areas of the peaks. Calculate the chromatographic purity, in percentage, of the portion of Cilastatin Sodium taken by the formula:
100rC / (rT rB rA)in which rC is the area of the cilastatin peak obtained from the Test solution; rT is the sum of the areas of all the peaks obtained from the Test solution; rB is the sum of the areas of all the peaks obtained from the Solvent; and rA is the response of the peak, if any, of nonretained substances, such as acetone, at the solvent front obtained from the Test solution: not less than 98.5% is found. Calculate the percentage of each impurity in the portion of Cilastatin Sodium taken by the formula:
100ri / (rT rB rA)in which ri is the peak area for each impurity in the chromatogram obtained from the Test solution and the other terms are as defined above: not more than 0.5% of any individual impurity is found.
Assay Transfer about 300 mg of Cilastatin Sodium, accurately weighed, to a suitable beaker, add 30 mL of methanol, and dissolve by swirling. Add 5 mL of water, and titrate potentiometrically with 0.1 N hydrochloric acid to a pH of about 3. Then titrate with 0.1 N sodium hydroxide until three inflection points have been observed. Calculate the titer difference, in mL, between the first and third inflection points. Each mL of 0.1 N sodium hydroxide is equivalent to 19.022 mg of C16H25N2NaO5S.
Auxiliary Information Please check for your question in the FAQs before contacting USP.
USP35NF30 Page 2661